Dessislava I. Dimitrova
Internal Medicine
1401 Whitehorse Mercerville Rd Ste 219
Trenton, NJ 08619
Trenton, NJ 08619
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Effect of nipocalimab on IgG responses to vaccinations and viral infections in patients with IgG autoantibody-mediated diseases: Post hoc analyses of three randomized, placebo-controlled trials.
Journal: Human vaccines & immunotherapeutics
Published: May 05, 2026
A Phase 1 Bioequivalence Study to Assess the Pharmacokinetics, Safety and Tolerability of Guselkumab After a Single-Dose Administration via Two Subcutaneous Injection Devices in Healthy Volunteers.
Journal: Clinical pharmacology in drug development
Published: October 23, 2025
A randomized, open-label study on the effect of nipocalimab on vaccine responses in healthy participants.
Journal: Human vaccines & immunotherapeutics
Published: April 15, 2025
Annual Primary Care 2030 Convening: Creating an Enabling Ecosystem for Person-Centered Primary Healthcare Models to Achieve Universal Health Coverage in Low- and Middle-Income Countries.
Journal: Annals of global health
Published: September 03, 2020
Primary Care 2030: Creating an Enabling Ecosystem for Disruptive Primary Care Models to Achieve Universal Health Coverage in Low- and Middle-Income Countries.
Journal: Annals of global health
Published: February 18, 2020
Evaluation of Cardiovascular Disease Risk in HIV-1-Infected Patients Treated with Darunavir.
Journal: Drugs in R&D
Published: July 12, 2018
Peginterferon Lambda-1a Is Associated with a Low Incidence of Autoimmune Thyroid Disease in Chronic Hepatitis C.
Journal: Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research
Published: September 17, 2015
Cardiac dysfunction associated with a nucleotide polymerase inhibitor for treatment of hepatitis C.
Journal: Hepatology (Baltimore, Md.)
Published: July 14, 2014
Sofosbuvir and daclatasvir combination therapy in a liver transplant recipient with severe recurrent cholestatic hepatitis C.
Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Published: November 30, 2012
Case report of successful peginterferon, ribavirin, and daclatasvir therapy for recurrent cholestatic hepatitis C after liver retransplantation.
Journal: Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
Published: June 19, 2012
Preliminary study of two antiviral agents for hepatitis C genotype 1.
Journal: The New England journal of medicine
Published: January 20, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026